Edition:
United Kingdom

Seres Therapeutics Inc (MCRB.OQ)

MCRB.OQ on NASDAQ Stock Exchange Global Select Market

7.48USD
21 Sep 2018
Change (% chg)

$0.04 (+0.54%)
Prev Close
$7.44
Open
$7.46
Day's High
$7.58
Day's Low
$7.27
Volume
158,521
Avg. Vol
45,574
52-wk High
$17.33
52-wk Low
$6.65

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 4.61 -0.683
Mar '18 3.97 -0.687
FY 2017 Dec '17 3.06 -0.714
Sep '17 23.01 -0.171
Jun '17 3.01 -0.694
Mar '17 3.02 -0.631
FY 2016 Dec '16 3.04 -0.626
Sep '16 13.02 -0.464
Jun '16 3.00 -0.705
Mar '16 0.00 -1.308
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 7 12.31 23.43 0.00 18.00
Quarter Ending Dec-18 7 6.87 20.17 0.00 3.00
Year Ending Dec-18 7 27.47 35.44 8.58 13.08
Year Ending Dec-19 6 24.54 67.33 8.75 35.04
Earnings (per share)
Quarter Ending Sep-18 7 -0.50 -0.23 -0.78 -0.61
Quarter Ending Dec-18 7 -0.61 -0.33 -0.86 -1.01
Year Ending Dec-18 7 -2.48 -2.23 -2.87 -2.88
Year Ending Dec-19 6 -2.57 -2.14 -3.28 -2.48
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) 21.87 114.98 5.74
Price to Book (MRQ) 5.48 15.51 5.00
Price to Tangible Book (MRQ) 5.49 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 78.85 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 0.30 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago 286.35 80.36 5.64
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -0.69 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago -16.86 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 6.86 5.46 3.03
LT Debt to Equity (MRQ) 11.21 35.27 12.51
Total Debt to Equity (MRQ) 11.21 37.09 16.85
Interest Coverage (TTM) -- -102.34 32.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.16
EBITD Margin (TTM) -419.56 -- --
EBITD - 5 Yr. Avg -- -600.62 10.68
Operating Margin (TTM) -448.70 -759.68 4.33
Operating Margin - 5 Yr. Avg. -- -621.65 6.11
Pre-Tax Margin (TTM) -441.38 -733.53 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.35 6.51
Net Profit Margin (TTM) -441.38 -734.90 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.40 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 173,858 23,229,030 860,305,024
Net Income/Employee (TTM) -767,370 3,144,146 101,198,978
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.08 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -37.30 -0.15 11.13
Return on Assets - 5 Yr. Avg. -- 3.51 12.40
Return on Investment (TTM) -41.51 1.79 14.61
Return on Investment - 5 Yr. Avg. -- 2.56 16.13
Return on Equity (TTM) -76.34 3.28 16.33
Return on Equity - 5 Yr. Avg. -- 3.43 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 1.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Seres Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -16.99 -19.85 9 52
13 Week 7.00 1.79 62 66
26 Week 9.86 1.51 63 80
52 Week 4.47 -11.45 55 50
YTD 20.40 5.74 60 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.31%
# of Holders: 122
Total Shares Held: 31,947,904
3 Mo. Net Change: -548,071
# New Positions: 12
# Closed Positions: 16
# Increased Positions: 50
# Reduced Positions: 45
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.